MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1002/pbc.31675

Медицинская библиотека · Pediatric blood & cancer · 2025

Soluble Thrombomodulin Is Associated With Endothelial Dysfunction Syndromes After Pediatric Hematopoietic Stem Cell Transplantation.

Horan Denise Elbæk, Johansson Pär I, Ifversen Marianne, Nielsen Claus H, Müller Klaus, Kielsen Katrine

СтатьяПеревод в очереди

Аннотация

BACKGROUND

Allogeneic hematopoietic stem cell transplantation (HSCT) is challenged by endothelial dysfunction-related syndromes like sinusoidal obstruction syndrome (SOS), capillary leak syndrome (CLS), and severe acute graft-versus-host disease (aGvHD). We investigated soluble thrombomodulin (sTM), an endothelial damage marker, in relation to endothelial dysfunction syndromes after pediatric HSCT.

PROCEDURE: We measured sTM levels in 113 children before conditioning until Day +180 after HSCT.

RESULTS

Plasma levels of sTM increased significantly after conditioning, particularly in patients receiving busulfan-based regimens (Day +7: 5.0 vs. 7.6 ng/mL, p = 0.0023), and remained elevated until Day +180 after HSCT. Children diagnosed with SOS (n = 51) had significantly higher sTM levels at Days +7 and +14 than children without SOS (Day +7: 7.3 vs. 5.0 ng/mL, p = 0.017). High sTM levels at Day +14 were associated with aGvHD Grade III-IV (n = 8) in multivariable analysis (OR = 3.0 per quartile increase in sTM, p = 0.021). Likewise, children diagnosed with CLS (n = 15) displayed higher sTM levels at Day +7 (5.3 vs. 8.0 ng/mL, p = 0.037), while sTM levels were not associated with engraftment syndrome or bacteremia.

CONCLUSION

High sTM levels early after pediatric HSCT are associated with the development of SOS, CLS, and severe aGvHD. These results suggest that conditioning-induced endothelial damage and activation of pro-thrombotic environment play key roles in the pathogenesis of these syndromes, indicating that sTM may prove clinically useful to guide early diagnosis and treatment of endothelial damage syndromes.

Для цитирования: Horan Denise Elbæk, Johansson Pär I, Ifversen Marianne, Nielsen Claus H, Müller Klaus, Kielsen Katrine. Soluble Thrombomodulin Is Associated With Endothelial Dysfunction Syndromes After Pediatric Hematopoietic Stem Cell Transplantation.. Pediatric blood & cancer. 2025. DOI: 10.1002/pbc.31675.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.